Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Central Nervous System Neoplasms 36Neuroblastoma 35Brain Neoplasms 25Medulloblastoma 22Astrocytoma 10Glioma 8Glioblastoma 7Choroid Plexus Neoplasms 7Rhabdoid Tumor 6Oligodendroglioma 6Neuroectodermal Tumors, Primitive 6Ependymoma 6Breast Neoplasms 6Sarcoma 5Ovarian Neoplasms 5Neoplasms 5Ganglioneuroblastoma 5Esthesioneuroblastoma, Olfactory 5Carcinoma, Non-Small-Cell Lung 5Testicular Neoplasms 4Testicular Germ Cell Tumor 4Small Cell Lung Carcinoma 4Lung Neoplasms 4Head and Neck Neoplasms 4Gliosarcoma 4Thyroid Neoplasms 3Teratoma 3Squamous Cell Carcinoma of Head and Neck 3Seminoma 3Endodermal Sinus Tumor 3

Interventions

Paclitaxel 2pegfilgrastim 1Taxes 1Lapatinib 1Ifosfamide 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × Cisplatin × CNS × Clear all
NCT00470366 2017-11-28

Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
60 enrolled 11 charts
CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Dysgerminoma, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡